Summary: In the neonatal and postnatal development of rat TMJ, tenascin-C and -X were detected in the muscle, bone matrix, connective tissue around the bone, and blood vessel of rats at E18 (18-days old embryo), 0-, and 5-days postnatal. The reaction of tenascin-X was also found in the connective tissue around the mandibular condyle. The mRNA of tenascin-C (600 bp) and -X (588 bp) was also detected in the developmental muscle with the level of tenascin-C mRNA moderately decreased during development. Therefore, tenascin-C and -X may have different effects on the connective tissue during development of TMJ.
Tenascin is expressed in the mesenchyme surrounding fetal rat mammary gland, hair follicle, teeth (Chiquet-Ehrismann et al., 1986), muscle spindle (Maier and Mayn, 1987) , cancer cell nests (Yoshida et al., 1999) , overgrowth oral mucosa (Mighell et al., 1996) , and neutral tube and somite. In the mutant mice lacking tenascin, morphological property is similar to that of normal mice (Saga et al., 1992) . Tenascin was identified in several structures of the joint, including the articular cartilages (Milam et al., 1991) . Tenascin mRNA was only expressed in the hypertrophic synovial membranes with tenascin produced in synovial cells, vascular endothelial cells and fibroblasts in the portion of human temporomandibular joint (TMJ) with internal derangement (Yoshida et al., 1996 (Yoshida et al., , 2002 .
However, the tenascin family is composed of tenascin-C, -R, -W, -X and -Y with EGFL repeats, fibronectin type III domains and fibrinogen globe. Tenascin-C, in particular, was found in myotendinous junctions and osteotendinous junctions (Kannus et al., 1998 , 1999) . In normal tissue, tenascin-C expression in the extracellular matrix was found in the basement membrane of masticatory mucosa (Sloan et al., 1990 ) and keratinized epithelium (Schnyder et al., 1997) . Tenascin-X was found in the tendon of embryonic rats (Burch et al., 1995) . Burch et al. (1997) reported that 21-hydroxylase deficiency and connective tissue disorder in skin and joint hyperextensibility were found in the contiguous-gene syndrome involving tenascin-X. The different distributions of tenascin-C and -X were found in various organs (Geffrotin et al., 1995) . Tenascin-X was mainly observed in tendon, ligaments in adult pigs and testes and skeletal muscle in fetal pigs (Geffrotin et al., 1995) . Therefore, these distributions between tenascin-C and -X provide some information on the relationship between formation of bone matrix and muscle fiber in the developed TMJ in fetal and postnatal rat. In our study, we tried to examine the distribution of tenascin-C and -X in rat mandibular and temporal bones and masseter muscle in rat TMJ, and the expression of tenascin-C and -X mRNA in rat masseter muscle.
Materials and Methods
The laboratory animals were obtained from Nippon Medical Science Animal Resource Laboratory and were bred at Animal Testing Center of the Dept. of Dentistry, Nippon Dental University. A group of four male Wistar rats at 18E (18-days old embryo), 20E (20-days old embryo), 0-, and 5-postnatal days was used. These rats were humanely killed using an overdose of pentobarbital. The TMJ was then removed and used for light microscopy.
Light microscopic study
After being fixed overnight in a solution of 10% formalin and washed in running water for 12 hours, samples were immediately embedded into OCT (Tissue Tek II) compound and frozen in liquid nitrogen. Frozen frontal sections (about 10 mm thick) of the mandible were cut with a cryostat, and used for immunohistochemical staining. The sections for immunohistochemical observation were then mounted with Prolong 2 Antifade kit (Molecular Probe Inc., OR, USA) and examined under a confocal laser scanning microscopy (TCS-SP, Leika; Wetzlar, Germany). After observation, these sections for each stage were stained with hematoxylineosin.
Immunofluorescence antibodies
The distribution of tenascin-C and tenascin-X was examined using immunohistochemical staining. Sections were incubated with 1 : 50 dilution of BSA in PBS for 30 min at room temperature, in order to prevent non-specific adsorption of the antibodies. Separate incubations were carried out with the following primary antibodies with PBS at 4 C overnight: goat polyclonal antibodies against tenascin-C of human origin (mouse monoclonal antibody to tenascin-C, TG6044, Affiniti Exetre, UK) and against a peptide mapping at the carboxy terminus of tenascin-X of human origin (corresponding antibody against rat, SC-5498; Santa Cruz Biotechnology, Inc. CA, USA). After the sections and controls (stained with 5% PBS) were washed with PBS, a second incubation with the secondary antibodies was similarly carried out for 2 hours. The secondary antibodies used were fluorophore-labeled goat antibodies against IgG (mouse IgG for tenascin-C, T-862 Molecular Probes, Oregon, USA; goat IgG for tenascin-X, 81-1611, Zymed Lab. Inc., CA, USA).
Isolation of total RNA
Samples were scrapped off and stored at À80 C until ready for use. The masseter muscle was thawed, cut into small pieces and total RNA was extracted with Quick Prep Total RNA Extraction Kit (Amersham Pharmacia Biotech) as per manufacture protocol. Contaminating DNA was removed using an RNase-free DNase (DNA-free, Ambion, Austin, Texias), and the total RNA was quantified by means of spectrophotometry. The samples were stored at À80 C until further use.
RT-PCR
The DNA oligonucleotide primers were selected from the nucleotide sequences that have been published for each gene (Table 1 ). 1 mg of total RNA was reverse transcribed in a 25 ml of the reaction mixture at 50 C for 1 hr. This reaction mixture consisted of 0.4 mM oligo(dT) 15 primer, 1 mM each dNTP, 20 units of RNase inhibitor (TaKaRa), 2.5 units of AMV reverse transcriptase (TaKaRa), 25 mM Tris-HCl (pH8.3), 50 mM KCl, 2 mM of DTT and 5 mM MgCl 2 . For the negative control, a total RNA sample without added reverse transcriptase was tested for DNA contaminants. For PCR, 1 ml of the cDNA mixture was added to 25 ml of master mix. This master mix consisted of 200 mM each dNTP, 0.4 mM each sense primer and antisense primer, 0.625 units of Ampli Taq Gold (Applied Biosystems, Foster, CA). The reactions were performed under different annealing temperatures and cycle repetitions: 60 C and 29 cycles for GAPDH; 62 C and 38 cycles for TN-C; 60 C and 36 cycles for TN-X. An aliquot of each PCR product was separated on a 1.5% agarose gel and stained with ethidium bromide. The stained gels were photographed under ultraviolet illuminator using Polaroid film. The intensity of the bands was quantified using Image Gause software (Fuji Film, Tokyo, Japan). 
Results
Distribution of tenascin-C and -X using a confocal laser scanning microscopy The extracellular matrix contents (tenascin-C and -X) of the TMJ are shown in Table 2 . Tenascin-C and -X were detected in the muscle, bone matrix, connective tissue around the bone, and blood vessels in each stage. A concentration of tenascin-X was detected in the connective tissue around the mandibular condyle from E18 (18-days old rat embryo) to 5-post-natal days. In the disc-like interior of the connective tissue, tenascin-C and tenascin-X were mainly found on the fibroblast-like cells on 0-day postnatal. During development, tenascin-C was detected mainly on the connective tissue layer around the bone from 0-post-natal days. In myotendinous junctions, the reaction of tenascin-C and -X was detected on the connective tissue along the muscle fiber in the examined stages (Fig. 1) .
Expression of mRNA in tenascin-C and -X
The level of mRNA in tenascin-X was a constant low at 0-day and 21-days (Fig. 2 ). In contrast, the level of mRNA in tenascin-C was low at 21-day compared with that of 0-days and showed a lower level than that of tenascin-X (Fig. 2) .
Discussion
Five tenascin proteins (tenascin-C, -R, -W, -X, and -Y) have been found among which these tenascin cytotactin (tenascin-C) plays a major function in development, tissue remodeling and cell adhesive activity (Jones and Jones, 2000) . Tenascin-C was reportedly found in the keratinized cell of human (Schnyder et al., 1997) as well as in the fibrocatilaginous and tendon region (Riley et al., 1996) and myotendinous junction, tendon cell, tendinous collagen fiber, chondrocytes of articular cartilage, and osteotendinous junction. It is associated with the mechanical loading and was found around blood vessels and keratinocytes of oral mucosa (Mighell et al., 1996) . In our results, tenascin-C was also detected in the muscle, bone matrix, connective tissue around the bone, and blood vessels during development; however, mRNA of tenascin-C was very low in the muscle of postnatal stages. In other words, tenascin-C is detected at various levels during development. Talts et al. (1997) reported that tenascin-C is associated with the blood vessels only during in development. In contrast, tenascin-X was found in adult and fetal skeletal and heart muscle and blood vessels (Matsumoto et al., 1994) . Burch et al. (1995) also reported that tenascin-X was at first Table 2 . Localization of the tenascin-C and -X in the rat TMJ of development associated with formation of blood vessels and second cell migration and morphogesis in the connective tissue surrounding muscle in the heat development. In our observation, tenascin-C and -X were also detected in the connective tissue around the bone, and blood vessels on fetal and post-natal stages. In particular, tenascin-X was located in the connective tissue around the mandibular condyle from E18 to 5-post-natal days. Yoshida et al. (2002) reported that mRNA tenascin was identified only in the fibroblast and vascular endothelial cells of the synovial membrane TMJ with internal derangement. In the adult primate TMJ, tenascin was found mainly in the prechondroblastic layer of the mandibular condyle and temporal bone (Milam, 1991) . In rat TMJ, tenascin-C was found on the disc from E18. Vä kevä et al. (1990) reported that tenascin was localized the in connective tissue with osteogenic mesenchyme surrounding the formation of mandibular bone from newborn to 20 day-old post-natal rat. However, the levels of tenascin were very low in fibrils of early chick embryonic stage (McCarthy, 1991) . Therefore, the localization of tenascin is varied during development in the embryonic stage.
There is also different detection of mRNA tenascin-C in rat masseter muscle during development on post-natal satges. Kannus (1998) reported that tenascin-C was localized in the myotendinous junction and osteotendinous junctions. During development, regulated the tenascin-C is closely to the musclature of masseter muscle. In our study, the different concentration of tenascin-C and -X was found on the disc from birth. Formation of TMJ, the concentration of tenascin-C and -X gave different effects during development.
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